Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001137050-13-000261
Filing Date
2013-08-14
Accepted
2013-08-14 13:14:55
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 f10q20130630_final.htm 10-Q 355341
2 exhibit311.htm EX-31 5877
3 exhibit312.htm EX-31 5926
4 exhibit321.htm EX-32 2220
5 exhibit322.htm EX-32 2190
  Complete submission text file 0001137050-13-000261.txt   3282338

Data Files

Seq Description Document Type Size
6 avrt-20130630.xml EX-101.INS 321639
7 avrt-20130630.xsd EX-101.SCH 23310
8 avrt-20130630_lab.xml EX-101.LAB 98844
9 avrt-20130630_pre.xml EX-101.PRE 94824
10 avrt-20130630_cal.xml EX-101.CAL 4547
11 avrt-20130630_def.xml EX-101.DEF 25038
Mailing Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000
Business Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000 852-2317-1291
ANTIVIRAL TECHNOLOGIES, INC. (Filer) CIK: 0001445226 (see all company filings)

EIN.: 261188469 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53449 | Film No.: 131036586
SIC: 6770 Blank Checks